Dmitriy Rudenko
Overview
Explore the profile of Dmitriy Rudenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Truncating Variant in Gene Is Associated With Limb-Girdle Type Muscular Dystrophy and Cardiomyopathy
Kiselev A, Vaz R, Knyazeva A, Sergushichev A, Dmitrieva R, Khudiakov A, et al.
Front Genet
. 2019 Jul;
10:608.
PMID: 31297131
Even though genetic studies of individuals with neuromuscular diseases have uncovered the molecular background of many cardiac disorders such as cardiomyopathies and inherited arrhythmic syndromes, the genetic cause of a...
2.
Kiselev A, Vaz R, Knyazeva A, Khudiakov A, Tarnovskaya S, Liu J, et al.
Hum Mutat
. 2018 Jun;
39(9):1161-1172.
PMID: 29858533
Mutations in FLNC for a long time are known in connection to neuromuscular disorders and only recently were described in association with various cardiomyopathies. Here, we report a new clinical...
3.
Mofid A, Newman N, Lee P, Abbasi C, Matkar P, Rudenko D, et al.
J Am Heart Assoc
. 2017 Feb;
6(2).
PMID: 28174168
Background: Cardiomyocyte-specific transgenic mice overexpressing S100A6, a member of the family of EF-hand calcium-binding proteins, develop less cardiac hypertrophy, interstitial fibrosis, and myocyte apoptosis after permanent coronary ligation, findings that...
4.
Matkar P, Singh K, Rudenko D, Kim Y, Kuliszewski M, Prudhomme G, et al.
Oncotarget
. 2016 Aug;
7(43):69489-69506.
PMID: 27542226
Pancreatic ductal adenocarcinoma (PDAC) is characterized by an intense fibrotic reaction termed tumor desmoplasia, which is in part responsible for its aggressiveness. Endothelial cells have been shown to display cellular...
5.
Cao W, Rosenblat J, Roth N, Kuliszewski M, Matkar P, Rudenko D, et al.
Arterioscler Thromb Vasc Biol
. 2015 Sep;
35(11):2401-11.
PMID: 26381870
Objective: MicroRNAs are involved in many critical functions, including angiogenesis. Ultrasound-targeted microbubble destruction (UTMD) is a noninvasive technique for targeted vascular transfection of plasmid DNA and may be well suited...
6.
Lineen J, Kuliszewski M, Dacouris N, Liao C, Rudenko D, Deva D, et al.
Can J Kidney Health Dis
. 2015 Aug;
2:25.
PMID: 26229686
Background: Left ventricular hypertrophy (LVH) is commonly found in chronic dialysis (CD) recipients, and is associated with impaired microvascular cardiac perfusion and heart failure. In response to LVH and cardiac...
7.
Qiang B, Lim S, Lekas M, Kuliszewski M, Wolff R, Osherov A, et al.
Can J Cardiol
. 2014 Sep;
30(11):1444-51.
PMID: 25249499
Background: Perlecan is a heparan sulfate proteoglycan (HSPG) constituent of the extracellular matrix with roles in cell growth, differentiation, and angiogenesis. The role of the HS side chains in regulating...
8.
Lee P, Rudenko D, Kuliszewski M, Liao C, Kabir M, Connelly K, et al.
Cardiovasc Res
. 2014 Jan;
101(3):423-33.
PMID: 24403316
Aims: The aim of this study was to investigate anti-apoptotic gene therapy using ultrasound-mediated plasmid delivery of survivin, an inhibitor of apoptosis protein, to prevent apoptosis and to attenuate left...
9.
Fujii H, Matkar P, Liao C, Rudenko D, Lee P, Kuliszewski M, et al.
Mol Ther Nucleic Acids
. 2013 May;
2:e94.
PMID: 23695537
Ultrasound-targeted microbubble destruction (UTMD) can be used to deliver silencing gene therapy to tumors. We hypothesized that UTMD would be effective in suppressing angiogenesis within tumors, and that modulation of...
10.
Smith A, Kuliszewski M, Liao C, Rudenko D, Stewart D, Leong-Poi H
J Am Coll Cardiol
. 2012 Apr;
59(14):1320-8.
PMID: 22464261
Objectives: The aim of this study was to compare temporally separated vascular endothelial growth factor (VEGF) and angiopoietin (Ang)-1 delivery with concomitant delivery or single VEGF delivery, for therapeutic angiogenesis...